ALX Oncology Holdings Inc. (ALXO) vs Anavex Life Sciences Corp. (AVXL)

A side-by-side comparison of ALX Oncology Holdings Inc. and Anavex Life Sciences Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALXO vs AVXL

growth of $100 · dividends reinvested · last 6y
ALXO -96.0% (-41.4%/yr)AVXL -63.7% (-15.5%/yr)AVXL compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$4$36
ALXO AVXL

ALXO vs AVXL: by the numbers

  • •ALXO is the larger company ($163M vs $152M market cap).

Metrics side by side

Valuation

MetricALXOAVXL
P/B ratio1.201.36

Profitability

MetricALXOAVXL
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-59.40%-21.38%
ROIC-56.53%-27.25%

Growth (annualized)

MetricALXOAVXL
Total return CAGR (5Y)-56.07%-37.74%

Frequently asked

How have ALXO and AVXL total returns compared?
Over the past 5 years, ALXO delivered -56.07% and AVXL delivered -37.74% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.